Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hendriks

Showing results (331-340 of 344) with videos related to

Pageof 35
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 8, 2020
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort studyKarlijn de Joode, Daphne W Dumoulin, Jolien Tol, et al.
International Journal of Cancer|October 16, 2023
Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancerArd van Veelen, G D Marijn Veerman, Marjon V Verschueren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2024
Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery ProtocolKarlijn Verkerk, Tijmen J W T van der Wel, Laurien J Zeverijn, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2026
Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumabYan Wang, Laura H Bukkems, Johan G C van Hasselt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2026
First-line integration of Local Ablative Therapy (LAT) with EGFR Tyrosine Kinase Inhibitors (TKIs) in advanced EGFR+ NSCLC: A Systematic Review and Meta-AnalysisLeonardo Brunetti, Giacomo Colella, Giuseppina Rita Di Fazio, et al.
Lung Cancer (Amsterdam, Netherlands)|November 30, 2024
Impact of HA-PCI on self-reported cognitive functioning and brain metastases in small-cell lung cancer: Pooled findings of NCT01780675 and PREMER trialsHaiyan Zeng, Sanne B Schagen, Lizza E L Hendriks, et al.
Frontiers in Oncology|March 27, 2023
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)Marinda Meertens, M Benthe Muntinghe-Wagenaar, Barend J Sikkema, et al.
Targeted Oncology|April 20, 2023
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung CancerRob Ter Heine, Michel M van den Heuvel, Berber Piet, et al.
ESMO Open|January 21, 2026
Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancerE J van Dijk, M M Smeenk, F Bensch, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 10, 2019
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus ReportAnne-Marie C Dingemans, Lizza E L Hendriks, Thierry Berghmans, et al.
Pageof 35

Showing results (331-340 of 344) with videos related to

Sort By:
Pageof 35
European Journal of Cancer (Oxford, England : 1990)|November 8, 2020
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort studyKarlijn de Joode, Daphne W Dumoulin, Jolien Tol, et al.
International Journal of Cancer|October 16, 2023
Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancerArd van Veelen, G D Marijn Veerman, Marjon V Verschueren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2024
Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery ProtocolKarlijn Verkerk, Tijmen J W T van der Wel, Laurien J Zeverijn, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2026
Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumabYan Wang, Laura H Bukkems, Johan G C van Hasselt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2026
First-line integration of Local Ablative Therapy (LAT) with EGFR Tyrosine Kinase Inhibitors (TKIs) in advanced EGFR+ NSCLC: A Systematic Review and Meta-AnalysisLeonardo Brunetti, Giacomo Colella, Giuseppina Rita Di Fazio, et al.
Lung Cancer (Amsterdam, Netherlands)|November 30, 2024
Impact of HA-PCI on self-reported cognitive functioning and brain metastases in small-cell lung cancer: Pooled findings of NCT01780675 and PREMER trialsHaiyan Zeng, Sanne B Schagen, Lizza E L Hendriks, et al.
Frontiers in Oncology|March 27, 2023
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)Marinda Meertens, M Benthe Muntinghe-Wagenaar, Barend J Sikkema, et al.
Targeted Oncology|April 20, 2023
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung CancerRob Ter Heine, Michel M van den Heuvel, Berber Piet, et al.
ESMO Open|January 21, 2026
Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancerE J van Dijk, M M Smeenk, F Bensch, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 10, 2019
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus ReportAnne-Marie C Dingemans, Lizza E L Hendriks, Thierry Berghmans, et al.
Pageof 35